Effect of one-year lumacaftor–ivacaftor treatment on glucose tolerance abnormalities in cystic fibrosis patients
Bastien Misgault, Eva Chatron, Quitterie Reynaud, Sandrine Touzet, Michel Abély, Laurent Melly, S. Dominique, Françoise Troussier, Olivia Ronsin-Pradel, M. Gérardin, Julie Mankikian, Laure Cosson, R. Chiron, Leila Bounyar, Michel Porzio, I. Durieu, Laurence Weiss, Romain Kessler, Laurence Kessler
Topics & Concepts
IvacaftorMedicineCystic fibrosisCystic fibrosis-related diabetesInternal medicineCystic fibrosis transmembrane conductance regulatorDiabetes mellitusImpaired glucose toleranceGastroenterologyGlucose tolerance testEndocrinologyType 2 diabetesInsulin resistanceCystic Fibrosis Research AdvancesBacterial biofilms and quorum sensingImmunodeficiency and Autoimmune Disorders